Background and Purpose-This study used ambulatory blood pressure (BP) monitoring to generate BP and heart rate (HR) profiles soon after stroke onset and evaluated the association between determined values and 3-month stroke outcomes. Methods-We analyzed 24-hour ambulatory BP monitoring records from 104 patients with acute ischemic stroke.
n acute hypertensive response occurs in up to 80% of all patients with acute stroke, but management of hypertension remains controversial because of the paucity of reliable evidence from randomized clinical trials. [1] [2] [3] Data from observational studies have suggested that high blood pressure (BP) is related to a poor outcome, 1,4 -6 whereas BP elevation during the acute phase might help to maintain cerebral perfusion pressure. 7, 8 Elevated BP generally falls and returns to prestroke levels during the initial days without therapeutic intervention. 1, 6, 9, 10 One systematic review found that the admission BP value was a useful indicator of stroke outcomes. 1 On the other hand, admission BP might be unreliable or misleading, because BP can transiently elevate or decline within several hours after stroke onset depending on the level of consciousness, physical activity, and mental stress of hospital admission. 11 Thus, consecutive BP monitoring during the initial hours or days might be a better prognostic predictor than admission BP values alone.
Compared with casually recorded BP, ambulatory BP monitoring (ABPM) has been proposed as a way to accurately evaluate clinical status, because a large number of records can be generated. [12] [13] [14] [15] However, whether BP profiles using ABPM during the acute phase are associated with stroke outcomes remains unclear.
The aim of this study was to evaluate the association of BP and heart rate (HR) profiles using ABPM devices early after stroke onset with 3-month outcomes.
Patients and Methods

Patient Population
We registered 136 consecutive Japanese patients with ischemic stroke who were admitted to our stroke care unit within 24 hours of symptom onset between January and December 2008. Of these, we excluded 6 patients who were dependent on activities of daily living (ADL) corresponding to a modified Rankin Scale Ն3 before stroke onset, 2 with severe subcutaneous hemorrhage in the arm, 3 infected with neurovirus, 7 who did not provide informed consent (principally orally and by written consent if needed), and 14 with incomplete ABPM recordings. Consequently, we analyzed data from 104 patients (40 women, 71.7Ϯ12.5 years). The open study design is described on the Web site of the Grant-in-Aid for Scientific Research (C, #20591039) from the Japan Society for the Promotion of Science.
Assessments of BP and HR
Baseline BP and HR values were recorded immediately after arrival at the emergency department (Day 0). Twenty-four-hour ABPM (TM-2431; A&D Company, Ltd) was started at 10 AM of the second and eighth hospitalization days (Days 1 and 7) on the left arm after a relevant difference between the 2 limbs was ruled out by conventional BP checks. Systolic/diastolic BP (SBP/DBP), pulse pressure (PP), and HR were automatically measured every 30 minutes for 24 hours.
We characterized BP and HR profiles by calculating the following values: mean, maximum, minimum, and coefficient of variation ([%]ϭSDϫ100/mean value) during 24 hours as well as mean values during 16 hours of the day (6 AM to 10 PM) and 8 hours of the night (10 PM to 6 AM). Patients were classified according to a fall (%) in mean SBP during the nighttime compared with the daytime as: dipper (fall Ն10%), nondipper (0%-10%), and riser (nocturnal SBP increased compared with daytime SBP).
Baseline Characteristics
The following baseline characteristics were investigated using the prospective database: sex, age, hypertension (BP Ն140/90 mm Hg before stroke onset or taking antihypertensive agents), diabetes mellitus (fasting blood glucose Ն7.0 mmol/L, hemoglobin A1c Ն6.5%, or taking antidiabetic agents), hyperlipidemia (total cholesterol Ն5.7 mmol/L, triglyceride Ն1.7 mmol/L, or taking antihyperlipidemic agents), atrial fibrillation (documented during hospitalization or history of atrial fibrillation), history of symptomatic ischemic stroke, and current smoking habit. Stroke subtypes were determined according to the Trial of ORG 10172 in Acute Stroke Treatment subtype classification system. 16 
Outcome
The outcome measurements comprised achieving independent ADL or a poor outcome at 3 months corresponding to modified Rankin Scale scores of Յ2 or Ն5, respectively.
Statistical Analysis
Data were statistically analyzed using JMP 7.0 software (SAS Institute Inc, Cary, NC). Statistical significance for the 2 groups was assessed using Student t test or Mann-Whitney U tests for continuous variables as appropriate and Pearson 2 tests for categorical variables. The 24-hour BP or HR time course between patients with and without each outcome was compared using the 2-way repeatedmeasures analysis of variance. Predictors for each outcome were determined by multivariate analyses based on the baseline characteristics and the 24-hour BP and HR profiles of the patients. A backward selection procedure was performed for each outcome using PϾ0.10 of the likelihood ratio test for exclusion. In addition, each outcome among quintile groups for mean 24-hour SBP on Day 1 was compared using multivariate analyses to search for the U-or J-shaped phenomenon. A level of PϽ0.05 was considered statistically significant.
Results
Outcomes and Related Factors
Of a total of 104 eligible patients, 82 (79%) had hypertension and 53 (51%) were treated with antihypertensive agents before stroke onset. Sixty-six (63%) patients reached independent ADL and 12 (11%) had a poor outcome (including death in 1 patient) at 3 months. Table 1 . Thirty patients were excluded from analysis on Day 7; 9 patients left the hospital, 10 refused to undergo further examination, 1 was not examined due to infection with methicillin-resistant Staphylococcus aureus, and recordings from 10 others were incomplete. Figure 2 shows the 24-hour time course of SBP and HR on Days 1 and 7 in patients with independent ADL (black lines). Between patients with and without independent ADL at 3 months, 2-way repeated measures analysis of variance showed significant differences in the 24-hour time course of SBP, PP, and HR on Day 1 (PϽ0.001, Ͻ0.001, and 0.003, respectively) and HR on Day 7 (PϽ0.001). After multivariate adjustment, the mean and minimum SBP (Pϭ0.004 and 0.035, respectively), mean DBP (Pϭ0.044), mean, minimum, and coefficient of variation of PP (Pϭ0.010, 0.010, and 0.031, respectively), and mean and maximum HR on Day 1 (Pϭ0.045 and 0.045, respectively) as well as mean HR on Day 7 (Pϭ0.022) were inversely associated with independent ADL (Table 2 ).
Figure 2 also shows the 24-hour time course of SBP and HR on Days 1 and 7 in patients with poor outcomes (gray lines). Two-way repeated-measures analysis of variance revealed significant differences in the 24-hour time course of SBP, DBP, and HR on Day 1 (Pϭ0.022, 0.007, and Ͻ0.001, respectively) and HR on Day 7 (PϽ0.001) between patients with and without poor outcomes at 3 months. After multivariate adjustment, the mean, maximum, and minimum SBP (Pϭ0.011, 0.010, and 0.012, respectively), mean and maximum DBP (Pϭ0.001 and 0.046, respectively), and mean, maximum, and minimum HR on Day 1 (PϽ0.001, 0.006, and 0.007, respectively) as well as mean HR on Day 7 (Pϭ0.012) were positively associated with a poor outcome ( Table 2) . Among the 104 patients, 16 (15%) received intravenous recombinant tissue-type plasminogen activator. Among these, 4 reached independent ADL and 3 had poor outcomes at 3 
Day and Night BP/HR Measurements
On Day 1, mean daytime SBP/DBP and HR values were 152.8Ϯ19.1/87.0Ϯ11.2 mm Hg and 69.8Ϯ11.4 beats/min, respectively, and nighttime values were 146.1Ϯ22.0/ 83.4Ϯ12.9 mm Hg and 66.6Ϯ12.1 beats/min, respectively. After multivariate adjustment, mean levels of daytime SBP, DBP, PP, and HR (Pϭ0.007, 0.047, 0.026, and 0.039, respectively) and nighttime SBP, PP, and HR (Pϭ0.025, 0.018, and 0.039, respectively) were inversely associated with independent ADL (Table 2 ). The mean levels of SBP, DBP, and HR both during the daytime (Pϭ0.007, Ͻ0.001, and 0.001, respectively) and nighttime (Pϭ0.022, 0.004, and Ͻ0.001, respectively) were positively associated with a poor outcome. Among the overall patients, 23 (22%) were dippers, 51 (49%) were nondippers, and 30 (29%) were risers (Table   3 ). Dipper pattern was not associated with either independent ADL or a poor outcome.
Mean daytime SBP/DBP and HR on Day 7 were 142.0Ϯ19.8/81.3Ϯ11.5 mm Hg and 68.4Ϯ11.3 beats/min, respectively, and these nighttime values were 135.5Ϯ20.6/ 76.9Ϯ13.1 mm Hg and 63.2Ϯ12.9 beats/min, respectively. After multivariate adjustment, the mean levels of both daytime and nighttime HR (Pϭ0.043 and 0.033, respectively) were inversely associated with independent ADL (Pϭ0.042) and positively associated with a poor outcome (Pϭ0.002), whereas mean BP profiles were not (Table 2 ). Among all of the patients, 18 (24%) were dippers, 36 (49%) were nondippers, and 20 (27%) were risers (Table 3) . Dipper pattern was not associated once again with either independent ADL or a poor outcome.
Discussion
In the present study, we measured BP and HR values during acute stroke using ABPM and determined their association with outcomes at 3 months. The first major finding was that lower BP profiles on Day 1 were independently associated with better clinical outcomes, whereas those on Day 7 were not. The second major finding was that lower HR profiles on Days 1 and 7 were also independently associated with better outcomes. In addition, we clarified SBP patterns during acute stroke as dipper, nondipper, or riser SBP, although they were not associated with outcomes.
Brain edema, hemorrhagic transformation, recanalization of occluded cerebral arteries, mental stress, and antihypertensive therapy are potential factors that could affect acute-phase BP levels. Of these, mass effect due to brain edema and hemorrhagic transformation causes elevated BP and vice versa. Brain edema and hemorrhagic transformation are key factors to link acute high BP and poor outcomes. 4, [17] [18] [19] The spontaneous decline in BP during the initial hours sometimes reflects the recanalization of occluded cerebral arteries, which often results in favorable outcomes. 20, 21 Mental stress of hospital admission contributes to elevated BP 11 ; release from the stress can lower BP and possibly improve clinical conditions. Some patients received antihypertensive therapy on the initial day or during the first week, mainly due to having extremely high BP levels or underlying cardiovascular diseases. Such therapy would affect BP and HR levels, although influence of acute BP-lowering on stroke outcomes has not been clarified. 22 The present results showed a highly significant association between 3-month outcomes and lower SBP and DBP on Day 1 on any whole day, daytime, or nighttime recording. Figure  3 shows a monotonous linear association between SBP levels OR and 95% CI for increase of 10 mm Hg or 10 beats/min as appropriate based on variables appearing in backward selection model. BP indicates blood pressure; HR, heart rate; SBP, systolic blood pressure; CV, coefficient of variation; DBP, diastolic blood pressure; PP, pulse pressure; NIHSS, National Institutes of Health Stroke Scale; OR, odds ratio; CI, confidence interval. *Statistically significant difference (PϽ0.05). †Independence analysis, adjusted for age, previous ischemic stroke, and baseline NIHSS score. ‡Poor outcome analysis, adjusted for age, previous ischemic stroke, current smoking habits, and baseline NIHSS score.
and outcomes. Some studies summarized in a meta-analysis 1 have identified a similar monotonous relationship, whereas others have demonstrated a U-shaped relationship between the initial BP and poor outcome with the best outcome being associated with SBP levels between 140 and 180 mm Hg. 23 Our study included few patients with stroke and severe heart failure who were generally hypotensive and had poor outcomes. The BP profiles of these patients on Day 7 did not predict outcomes at 3 months, partly because of a decrease in the effects of acute brain damage on cardiovascular modulation and therapeutic intervention including antihypertensive therapy during the initial week. The variability of BP in chronic stroke affects long-term outcomes, and the impact of BP variability in acute stroke on outcomes has recently been discussed. 24 -26 The present study is unique in that differences in diurnal and nocturnal BP levels, typical BP variability, were assessed in consecutive patients with acute stroke. The nondipper and riser patterns were identified in Ͼ75% of our patients on both Days 1 and 7. However, abnormal nocturnal BP dipping and the coefficient of variation of 24-hour BP levels were not associated with outcomes. The circadian rhythm of BP is disrupted during acute stroke and normalizes after a few weeks. [27] [28] [29] To determine the significance of the rhythm especially on Day 1 seems difficult because an acute consciousness disturbance as well as early initial intensive care for acute stroke might deprive patients of usual day/night life rhythms.
HR is an easily measurable predictor of total, cardiovascular, or noncardiovascular mortality in the general population. 30 -32 However, the role of HR seems to be understudied in patients with acute stroke. The present findings of a high HR on Days 1 and 7 as an indicator of poor chronic outcomes might be partly due to the mass effect of large infarcts, hemorrhagic transformation, and autonomic dysfunction during acute stroke, because they all cause tachycardia and poor outcomes. Atrial fibrillation is another key cause of both tachycardia and poor outcomes due to large embolic infarcts.
Our study had some limitations. First, this single-center observational study included a relatively small patient cohort, which would cause statistical bias. A single-center registration would cause institute-specific selection bias. At least, baseline characteristics, stroke subtypes, and baseline National Institutes of Health Stroke Scale score of the present patients were similar with known nationwide registration studies in Japan such as the Japan Multicenter Stroke Investigators' Collaboration study and the Japan Standard Stroke Registry Study. 33, 34 The small sample size, especially when grouped into smaller subgroups, caused wide 95% CI after multivariate analyses and limited statistical power. Second, because we started all ABPM measurements at the same time (10 AM), the intervals between stroke onset and ABPM differed among the patients.
Several factors can cause hypertensive response during acute stroke, including inadequately treated or undetected chronic hypertension before stroke onset, 35 increased sympathoadrenal tone with subsequent renin release and vasoconstriction because of impaired cardiac baroreceptor sensitivity, 36, 37 and stress responses to hospitalization, urinary retention, or conscious disturbance; some of these do not last long. In our cohort, any components of admission BP or HR did not predict chronic outcomes. Thus, BP should be frequently and consecutively measured to minimize the influence of unexpected factors and to accurately assess the clinical significance of acute BP levels. ABPM appears to be a practical and appropriate method for such assessment. A systemic review involving 20 studies with 5683 patients shows the advantage of ABPM over routine clinical BP measurement as a diagnostic tool for hypertension and suggests that ABPM leads to more appropriate targeting of antihypertensive treatment than the routine measurement. 38 In a general population from the Ohasama study, ABPM had stronger predictive power for stroke risk than did screening routine BP measurement. 39 Thus, ABPM may also have the strong predictive power for stroke outcomes. A randomized trial to control acute BP and HR levels is warranted to determine whether low BP and HR levels can directly improve outcomes or whether patients with predicted improved outcomes tend to have low BP and HR levels. No significantly difference in pattern distribution between patients with or without independent ADL or between those with or without poor outcomes.
BP indicates blood pressure; ADL, activities of daily living.
